Cross‑border M&A into Korea has accelerated, and merger control has moved to the top of deal checklists. The Korea Fair Trade Commission (KFTC) has refined notification exemptions, clarified remedies discussions, and signaled further updates to thresholds and filing scope. For foreign acquirers and funds, the message is clear: Korea’s merger control rules are evolving, and timing risk must be managed proactively.

This regulatory‑updates guide explains the 2024–2026 merger control changes, highlights Monopoly Regulation and Fair Trade Act Article 11, and offers practical filing strategies for foreign investors and deal teams. If you handle international transactions, these updates can affect both timing and structuring.

Korea merger control: the legal foundation

Korea’s merger control regime is grounded in the Monopoly Regulation and Fair Trade Act Article 11, which imposes notification obligations on certain business combinations. This article defines the types of transactions that trigger review, including stock acquisitions, mergers, asset transfers, and joint ventures.

The enforcement framework is managed by the KFTC, which reviews transactions for potential anti‑competitive effects. For foreign investors, the key challenge is aligning global deal timelines with Korea’s notification rules, which can be stricter than expected for transactions involving Korean subsidiaries or significant local sales.

What changed in 2024–2026

1) Expanded exemptions from notification

Recent amendments expanded the scope of exemptions from merger notifications. This is designed to reduce administrative burden for transactions with low competitive risk. For example, certain internal reorganizations, intra‑group transfers, and minor asset transfers may be exempt if they do not materially affect market structure.

However, the exemption analysis is not automatic. Foreign acquirers should not assume exemption based on internal restructuring alone. If the transaction changes control or has meaningful effect on a Korean market segment, the KFTC can still require notification.

2) Greater flexibility in remedies discussions

KFTC procedures now allow more formal dialogue on remedy proposals. This can benefit foreign acquirers by giving them a clearer roadmap for addressing competition concerns, rather than waiting for a formal remedy request late in the review process.

From a practical standpoint, this change favors early engagement. If the acquirer has a credible remedy package, presenting it early can shorten review and reduce uncertainty.

3) Heightened scrutiny of strategic sectors

Korea is paying closer attention to transactions involving critical technologies, infrastructure, or sensitive data. While this is not a formal new statute, it affects review intensity and timeframes. Foreign investors should expect deeper information requests in sectors such as semiconductors, defense‑adjacent industries, and platform businesses.

Filing thresholds and practical triggers

Although the legal framework is fixed in Fair Trade Act Article 11, the practical trigger is turnover and asset thresholds, as well as the presence of a Korean business. For foreign‑to‑foreign transactions, the main question is whether the parties have significant sales into Korea or operate Korean subsidiaries.

If the target has meaningful Korea revenue, or if the acquirer already has a Korea footprint, the KFTC may require notification even if the transaction is global in scope. This is a common surprise for foreign PE funds and strategic acquirers who assume Korea is a “small market” in the overall deal.

Why Korea revenue matters

The KFTC is not only focused on Korea‑based entities. It reviews whether a transaction affects competition within Korea, which can be true even if the main assets are overseas. A global acquisition of a company with strong Korea sales can trigger notification and delay closing.

Joint ventures and minority investments

Korea’s rules can also capture certain minority or joint‑venture transactions. If a transaction gives the investor the ability to influence management decisions or market behavior, it can be treated as a notifiable business combination. This is particularly relevant for consortium investments where governance rights are shared.

How to manage timing risk in Korea filings

Early screening is essential

Korea filing analysis should begin at the term‑sheet stage. If the deal team waits until signing, there may be insufficient time to complete the notification process before closing. This is especially important in competitive auction processes where timing is tight.

Align global and Korea timelines

Many foreign transactions close globally before local approvals are complete. If Korea notification is required, the deal documents should include clear conditions precedent and long‑stop dates that reflect KFTC review realities. A well‑structured closing schedule avoids penalties or forced divestiture risk.

Build a Korea‑specific data room

KFTC reviews require detailed market data, competitor analysis, and sales breakdowns. A separate Korea‑specific data room accelerates the process and reduces the risk of late information requests. For foreign acquirers, this also helps translate global sales data into Korea‑specific market definitions.

Case‑style examples for deal teams

Example 1: Global tech acquisition with Korea revenue

A US buyer acquires a European software company with significant Korea enterprise clients. Even though the target has no Korean subsidiary, the KFTC may require notification because the combined entity will affect the Korean software market. Early Korea revenue analysis is critical.

Example 2: PE fund buying a Korean manufacturing group

A PE fund acquires a Korean manufacturer with global exports. The transaction clearly triggers Korea notification. The key issue is how to define the relevant product market and provide sales data that the KFTC will accept. Preparing clean product segmentation avoids prolonged review.

Example 3: Joint venture in a regulated sector

Two global firms form a joint venture to enter Korea’s battery supply chain. The JV may be reviewed as a business combination if it has functional independence and market impact. In such cases, governance rights and market share analysis become decisive.

Interaction with other regulatory regimes

Merger control is not the only regulatory filter. Foreign acquirers should also consider:

Foreign investment reporting under the Foreign Investment Promotion Act Article 5
Industry‑specific licensing rules that may require prior approval
Sector‑specific foreign ownership limits

For complex transactions, these regimes can overlap, and the sequencing matters. Coordination can save weeks on the closing timeline and prevent contradictory filing narratives.

Drafting tips for transaction documents

Conditions precedent and long‑stop dates

Deal documents should clearly identify KFTC approval as a condition precedent where required. Long‑stop dates should include enough buffer for a second‑phase review or remedy negotiations.

Allocation of regulatory risk

The parties should define who bears the cost and risk of remedies. In competitive deals, sellers may push for “hell‑or‑high‑water” clauses, while buyers may seek limits on divestitures or behavioral remedies.

Cooperation obligations

KFTC review often requires detailed information from both parties. The SPA should set out cooperation obligations and timelines to avoid internal delays.

Practical tips / key takeaways

Monopoly Regulation and Fair Trade Act Article 11 is the core notification rule for business combinations.
Expanded exemptions and remedy discussions in 2024–2026 provide more flexibility but require early planning.
Foreign‑to‑foreign deals can still trigger KFTC review if Korean sales are material.
Build a Korea‑specific data room and timeline early to avoid closing delays.
Coordinate merger control with foreign investment reporting and sector licensing requirements.
Tie merger control planning into broader M&A services and litigation risk assessment.

Conclusion

Korea’s merger control regime is evolving toward more sophisticated review processes, and foreign investors should adjust their deal playbooks accordingly. The legal foundation in Fair Trade Act Article 11 remains steady, but exemptions, remedies, and review intensity are changing. The result is a higher premium on early analysis, clean documentation, and realistic closing timelines.

Korea Business Hub assists foreign investors and deal teams with Korea merger control strategy, notification preparation, and cross‑border regulatory coordination. If you are planning an M&A transaction involving Korea in 2026, we can help you navigate the process efficiently and avoid costly delays.

Korea Merger Control Updates 2024–2026: Filing Strategy Guide